Now that the major opioid lawsuit has been settled, we wouldn’t be surprised to see JNJ follow Merck's lead and break up into smaller pieces. Read More
spy
Filter
The top leader in the U.S. Senate this week introduced legislation to decriminalize cannabis, a political milestone that’s cheering pot investors. Read More
Second-quarter earnings results from the big banks so far have crushed expectations, indicating that the recovery and stock rally are on firm footing. Read More
Despite the robust economic recovery and surging stock market, many investors are succumbing to unwarranted fear. We separate facts from disinformation. Read More
If our hunch about the auto sector proves true over the remainder of this year, owning put options to leverage its woes could prove lucrative. Read More
This year’s market rotation from growth to value continues apace. The trick is to find the right bargain stocks and not get lured by “value traps.” Read More
Second-quarter earnings, as well as equity prices, are soaring in the energy sector. But green activists have put fossil fuel giants in a tough spot. Read More
Coke's stock swoon after getting snubbed by a sports hero underscores the high stakes among food and beverage firms. Here's how to profit from the sector. Read More
As we approach the end of Q2 2021, here’s a snapshot of the first six months in the U.S. marijuana industry, with projections for the rest of the year. Read More
As Q3 looms on the horizon, here are the investment themes that are poised for the greatest growth and those that are likely to lag. Read More